Longitude Capital Partners V, LLC - May 13, 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

Filing Manager
Longitude Capital Partners V, LLC
Reporting Manager
Longitude Capital Partners V, LLC
Security
CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
CTMX
Shares outstanding
158M shares
Disclosed Ownership
11.5M shares
Ownership
7.3%
Form type
SCHEDULE 13G
Date filed
5/20/2025, 09:00 PM
Date of event
May 13, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Longitude Capital Partners V, LLC 7.3% 11.5M 0 11.5M /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory
Longitude Venture Partners V, L.P. 7.3% 11.5M 0 11.5M /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory
Patrick G. Enright 7.3% 11.5M 0 11.5M /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Juliet Tammenoms Bakker 7.3% 11.5M 0 11.5M /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker